Showing results (171-180 of 327) with videos related to
Sort By:
Pageof 33
Journal of Surgical Oncology|July 1, 1989
Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancerS K Khoo, T Hurst, M J Webb, et al.Resuscitation Plus|December 23, 2022
In-hospital extracorporeal cardiopulmonary resuscitation for patients with an out-of-hospital cardiac arrest in a semi-rural setting: An observational study on the implementation of a helicopter emergency medical services pathwayE Ter Avest, M Tunnicliff, J Griggs, et al.Gynecologic Oncology|December 1, 1990
Prognostic significance of tumor ploidy in patients with advanced ovarian carcinomaS K Khoo, T Hurst, J Kearsley, et al.Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|January 1, 1994
Respiratory health status in swine producers relates to endotoxin exposure in the presence of low dust levelsJ E Zejda, E Barber, J A Dosman, et al.Cancer|April 15, 1988
Measurement of tumor cell activity in short-term primary culture. Clinical significance in women with ovarian cancerS K Khoo, T Hurst, M J Webb, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|November 1, 1988
Cisplatin chemotherapy of ovarian cancer: is short-term in vitro chemosensitivity predictive of long-term patient survival?S K Khoo, T Hurst, M J Webb, et al.Injury|June 4, 2011
'Time critical' rapid amputation using fire service hydraulic cutting equipmentM J McNicholas, S J Robinson, I Polyzois, et al.British Journal of Cancer|September 11, 2003
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerL M Forrest, D C McMillan, C S McArdle, et al.Clinical Chemistry and Laboratory Medicine|August 28, 2003
Tryptophan metabolites and brain disordersTrevor W Stone, Gillian M Mackay, Caroline M Forrest, et al.British Journal of Cancer|May 20, 2004
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancerL M Forrest, D C McMillan, C S McArdle, et al.Pageof 33